期刊文献+

消风宣窍汤对小鼠变应性鼻炎模型效应机制研究 被引量:9

Acting Mechanism of Xiaofeng Xuanqiao Decoction for on Mice Model of Allergic Rhinitis
下载PDF
导出
摘要 目的探讨消风宣窍汤对变应性鼻炎(AR)小鼠治疗效应及其相关机制。方法 48只BALB/c小鼠随机分为正常组,模型组,消风宣窍汤组,孟鲁斯特组,每组12只。采用OVA致敏建立小鼠AR模型。灌胃治疗1周,观测小鼠鼻部症状积分,体质量、胸腺和脾脏质量及指数,鼻黏膜组织学改变,血清总IgE、OVA特异性IgE以及胸腺IL-4、IL-17、IL-33、IFN-γ水平。结果消风宣窍汤能够显著降低AR小鼠鼻部症状,减轻变应性反应引起的体质量、胸腺质量、胸腺指数的增加,能够显著减少血清总IgE、OVA特异性IgE的水平,抑制胸腺IL-4、IL-17、IL-33、IFN-γ产生,且在降低胸腺IL-33水平方面,消风宣窍汤效果优于西药孟鲁斯特组。结论消风宣窍汤对AR小鼠疗效确切,其可能通过抑制胸腺细胞因子水平发挥抗AR效应。 OBJECTIVE To investigate the therapeutic effects of Xiaofeng Xuanqiao Decoction in treating mice with allergic rhinitis(AR) as well as its mechanism. METHODS 48 BALB/c mice were randomly divided into normal group, model group, Xiaofeng Xuanqiao Decoction group and montelukast group, with 12 mice in each group. OVA sensitized mice were established as the model with gavage for 1 week. Nasal symptom scores, weight, weight of thymus and spleen index, nasal mucosa changes, serum total IgE, ova specific. IgE and IL-4, IL-17, IL-33, IFN-γ levels in the thymus of mice were observed. RESULTS Xiaofeng Xuanqiao Decoction could significantly reduce nasal symptoms of AR in mice, reduce the increased weight, thymus weight and thymus index caused by allergic reaction. Besides, it could significantly reduce serum total IgE and ova specific IgE level, and inhibit the production of thymus IL-4, IL-17, IL-33, IFN-γ. In reducing the thymus IL-33 level, Xiaofeng Xuanqiao decoction was better than western medicine montelukast group. CONCLUSION Xiaofeng Xuanqiao Decoction has definite effects for AR in mice. The anti AR effects can be achieved by inhibiting the level of thymic cytokine.
出处 《南京中医药大学学报》 CAS CSCD 北大核心 2017年第2期212-216,共5页 Journal of Nanjing University of Traditional Chinese Medicine
基金 普通高校研究生实践创新计划项目(SJLX15_0443) 全国名老中医药专家传承工作室项目[国中医药人教发(2013)47号]
关键词 消风宣窍汤 变应性鼻炎 小鼠 胸腺 细胞因子 Xiaofeng Xuanqiao decoction allergic rhinitis mice thymus cytokine
  • 相关文献

参考文献4

二级参考文献35

  • 1张鑫,张俊龙,郭蕾,窦志芳.伏邪特征的诠释[J].中医研究,2006,19(4):11-14. 被引量:71
  • 2郭军雄,呼兴华,程畅和.从肝论治小儿支气管哮喘[J].中医儿科杂志,2006,2(6):22-23. 被引量:10
  • 3[1]Beasley R,Crane J,Lai CK,et al.Prevalence and etiology of asthma.J Allergy Clin Immunol,2000,105(2 Pt 2):466-472
  • 4[3]Constant SL,Bottomly K.Induction of Th1 and Th2 CD4+ T cell responses:the alternative approaches.Annu Rev Immunol,1997,15:297-322
  • 5[4]Abbas AK,Murphy KM,Sher A.Functional diversity of helper T lymphocytes.Nature,1996,383(6603):787-793
  • 6[5]Renauld JC.New insights into the role of cytokines in asthma.J Clin Pathol,2001,54(8):577-589
  • 7[6]Holgate ST.Science,medicine,and the future.Allergic disorders.BMJ,2000,320(7229):231-234
  • 8[7]Shi HZ,Li S,Xie ZF,et al.Regulatory CD4+CD25+ T lymphocytes in peripheral blood from patients with atopic asthma.Clin Immunol.,2004,113(2):172-178
  • 9[8]Sims JE,Williams DE,Morrissey PJ,et al.Molecular cloning and biological characterization of a novel murine lymphoid growth factor.J Exp Med,2000,192(5):671-680
  • 10[9]Zhou B,Comeau MR,De Smedt T,et al.Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice.Nat Immunol,2005,6(10):1047-1053

共引文献68

同被引文献66

引证文献9

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部